Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer


Tonyali O., Benekli M., Berk V., Coskun U., ÖZKAN M. , Yildiz R., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.139, ss.981-986, 2013 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 139 Konu: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00432-013-1409-1
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Sayfa Sayıları: ss.981-986

Özet

Combinations of trastuzumab with paclitaxel or capecitabine are effective therapies in human epidermal growth factor 2 (HER2)-positive metastatic breast cancer (MBC). This retrospective study evaluated the efficacy and toxicity of trastuzumab and paclitaxel plus capecitabine in the first-line therapy for patients with HER2-positive MBC.